$7.85 Billion is the total value of Orbimed Advisors's 132 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 25.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $414,569,000 | +28.2% | 3,388,386 | +28.4% | 5.28% | +43.5% |
| BIIB | Sell | BIOGEN INC | $363,323,000 | -13.0% | 1,281,200 | -4.0% | 4.63% | -2.6% |
| CELG | Buy | CELGENE CORP | $359,609,000 | +16.7% | 3,106,777 | +5.4% | 4.58% | +30.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $357,044,000 | -12.8% | 16,506,900 | -4.1% | 4.55% | -2.5% |
| AMGN | Sell | AMGEN INC | $340,932,000 | -16.1% | 2,331,800 | -4.3% | 4.34% | -6.2% |
| MRK | Buy | MERCK & CO INC | $271,697,000 | +24.1% | 4,615,200 | +31.6% | 3.46% | +38.9% |
| INCY | Buy | INCYTE CORP | $208,842,000 | +19.7% | 2,082,800 | +12.6% | 2.66% | +33.9% |
| SHPG | Buy | SHIRE PLCsponsored adr | $205,027,000 | -0.5% | 1,203,351 | +13.2% | 2.61% | +11.2% |
| LLY | Buy | LILLY ELI & CO | $201,453,000 | +23.0% | 2,739,000 | +34.2% | 2.57% | +37.6% |
| ABBV | Sell | ABBVIE INC | $183,164,000 | -31.3% | 2,925,000 | -30.8% | 2.33% | -23.2% |
| WMGI | Buy | WRIGHT MED GROUP N V | $174,288,000 | -3.4% | 7,584,334 | +3.1% | 2.22% | +8.1% |
| HUM | Buy | HUMANA INC | $170,651,000 | +127.8% | 836,400 | +97.5% | 2.17% | +154.9% |
| PFE | Buy | PFIZER INC | $167,853,000 | +40.3% | 5,167,900 | +46.3% | 2.14% | +57.0% |
| A | Sell | AGILENT TECHNOLOGIES INC | $165,378,000 | -5.5% | 3,629,900 | -2.3% | 2.11% | +5.8% |
| AGN | Sell | ALLERGAN PLC | $161,643,000 | -9.9% | 769,690 | -1.2% | 2.06% | +0.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $159,083,000 | +13.2% | 2,159,400 | +34.0% | 2.03% | +26.6% |
| HCA | Buy | HCA HOLDINGS INC | $148,203,000 | +49.3% | 2,002,200 | +52.6% | 1.89% | +67.1% |
| ANTM | New | ANTHEM INC | $146,875,000 | – | 1,021,600 | +100.0% | 1.87% | – |
| ARRY | Buy | ARRAY BIOPHARMA INC | $141,421,000 | +47.8% | 16,088,800 | +13.5% | 1.80% | +65.3% |
| REGN | REGENERON PHARMACEUTICALS | $130,427,000 | -8.7% | 355,300 | 0.0% | 1.66% | +2.2% | |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $126,626,000 | -23.5% | 1,351,400 | -1.6% | 1.61% | -14.4% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $121,688,000 | -34.0% | 1,120,000 | 0.0% | 1.55% | -26.1% | |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $112,809,000 | -13.1% | 799,500 | -2.1% | 1.44% | -2.8% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $111,090,000 | +237.3% | 18,241,398 | +205.2% | 1.42% | +277.6% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $110,719,000 | -29.9% | 7,241,300 | -27.2% | 1.41% | -21.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $105,546,000 | -1.0% | 1,274,100 | +10.6% | 1.34% | +10.8% |
| AET | Buy | AETNA INC NEW | $99,940,000 | +642.4% | 805,900 | +591.2% | 1.27% | +732.0% |
| JNJ | JOHNSON & JOHNSON | $98,850,000 | -2.5% | 858,000 | 0.0% | 1.26% | +9.2% | |
| ISRG | Sell | INTUITIVE SURGICAL INC | $92,272,000 | -32.2% | 145,500 | -22.5% | 1.18% | -24.1% |
| BOLD | AUDENTES THERAPEUTICS INC | $87,726,000 | +2.6% | 4,801,638 | 0.0% | 1.12% | +14.8% | |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $87,280,000 | -26.0% | 1,493,500 | -31.7% | 1.11% | -17.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $82,384,000 | -10.4% | 2,128,774 | +17.3% | 1.05% | +0.3% |
| CRVS | CORVUS PHARMACEUTICALS INC | $76,925,000 | -13.1% | 5,379,349 | 0.0% | 0.98% | -2.8% | |
| GILD | Sell | GILEAD SCIENCES INC | $75,556,000 | -52.5% | 1,055,100 | -47.5% | 0.96% | -46.9% |
| GKOS | GLAUKOS CORP | $74,774,000 | -9.1% | 2,180,000 | 0.0% | 0.95% | +1.7% | |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $73,370,000 | -10.1% | 1,472,700 | +25.9% | 0.94% | +0.5% |
| INSM | Buy | INSMED INC | $70,143,000 | -8.0% | 5,301,805 | +1.0% | 0.89% | +3.0% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $69,868,000 | -56.3% | 2,275,825 | -4.5% | 0.89% | -51.1% |
| AGNPRA | New | ALLERGAN PLCpfd conv ser a | $67,249,000 | – | 88,200 | +100.0% | 0.86% | – |
| MGLN | Buy | MAGELLAN HEALTH INC | $60,320,000 | +60.4% | 801,600 | +14.6% | 0.77% | +79.7% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $56,624,000 | +88.2% | 1,496,000 | +87.7% | 0.72% | +110.5% |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $55,857,000 | -13.9% | 6,071,440 | +10.3% | 0.71% | -3.7% |
| LOXO | LOXO ONCOLOGY INC | $55,495,000 | +22.7% | 1,728,000 | 0.0% | 0.71% | +37.3% | |
| THC | Buy | TENET HEALTHCARE CORP | $55,156,000 | +22.1% | 3,716,700 | +86.5% | 0.70% | +36.8% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $54,998,000 | +24.9% | 2,717,315 | +24.0% | 0.70% | +39.6% |
| MDT | MEDTRONIC PLC | $54,605,000 | -17.6% | 766,600 | 0.0% | 0.70% | -7.7% | |
| ACHN | ACHILLION PHARMACEUTICALS IN | $54,133,000 | -49.0% | 13,107,200 | 0.0% | 0.69% | -42.9% | |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $53,237,000 | -26.6% | 671,000 | -35.2% | 0.68% | -17.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $47,436,000 | -44.6% | 296,400 | -51.6% | 0.60% | -38.1% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $44,427,000 | – | 2,951,968 | +100.0% | 0.57% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $44,320,000 | +822.4% | 396,600 | +995.6% | 0.56% | +927.3% |
| COO | COOPER COS INC | $43,750,000 | -2.4% | 250,100 | 0.0% | 0.56% | +9.0% | |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $40,494,000 | +35.0% | 371,400 | +50.4% | 0.52% | +50.9% |
| SYK | Buy | STRYKER CORP | $37,896,000 | +53.6% | 316,300 | +49.2% | 0.48% | +71.9% |
| NTLA | INTELLIA THERAPEUTICS INC | $34,901,000 | -23.0% | 2,662,180 | 0.0% | 0.44% | -13.8% | |
| SELB | SELECTA BIOSCIENCES INC | $31,604,000 | +20.4% | 1,842,797 | 0.0% | 0.40% | +34.8% | |
| IMMUNOMEDICS INCnote 4.750% 2/1 | $29,769,000 | +16.8% | 30,000,000 | 0.0% | 0.38% | +30.7% | ||
| OTIC | OTONOMY INC | $29,416,000 | -12.6% | 1,850,094 | 0.0% | 0.38% | -2.1% | |
| VRAY | VIEWRAY INC | $28,571,000 | -30.8% | 9,127,990 | 0.0% | 0.36% | -22.6% | |
| BGNE | New | BEIGENE LTDsponsored adr | $27,436,000 | – | 903,700 | +100.0% | 0.35% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $26,924,000 | -82.5% | 496,200 | -81.2% | 0.34% | -80.4% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $23,930,000 | +33.1% | 850,100 | +26.6% | 0.30% | +48.8% |
| LBIO | LION BIOTECHNOLOGIES INC | $23,511,000 | -15.6% | 3,382,900 | 0.0% | 0.30% | -5.4% | |
| DMTX | DIMENSION THERAPEUTICS INC | $23,480,000 | -45.6% | 5,397,698 | 0.0% | 0.30% | -39.1% | |
| ILMN | Sell | ILLUMINA INC | $23,329,000 | -74.1% | 182,200 | -63.2% | 0.30% | -71.0% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $22,276,000 | -73.6% | 614,500 | -66.4% | 0.28% | -70.4% |
| XNCR | Buy | XENCOR INC | $22,115,000 | +21.3% | 840,237 | +12.9% | 0.28% | +35.6% |
| NLNK | Buy | NEWLINK GENETICS CORP | $20,475,000 | -29.7% | 1,991,700 | +2.8% | 0.26% | -21.4% |
| HUM | New | HUMANA INCcall | $20,403,000 | – | 100,000 | +100.0% | 0.26% | – |
| EHTH | Buy | EHEALTH INC | $19,383,000 | -4.7% | 1,820,000 | +0.3% | 0.25% | +6.5% |
| GLPG | Sell | GALAPAGOS NVspon adr | $18,198,000 | -38.5% | 283,500 | -38.1% | 0.23% | -31.2% |
| BLUE | Sell | BLUEBIRD BIO INC | $17,510,000 | -78.2% | 283,800 | -76.1% | 0.22% | -75.6% |
| ASMB | ASSEMBLY BIOSCIENCES INC | $16,975,000 | +68.5% | 1,397,100 | 0.0% | 0.22% | +87.8% | |
| SVA | SINOVAC BIOTECH LTD | $15,738,000 | 0.0% | 2,667,500 | 0.0% | 0.20% | +12.3% | |
| NTRA | NATERA INC | $14,944,000 | +5.4% | 1,276,190 | 0.0% | 0.19% | +18.0% | |
| IMMU | IMMUNOMEDICS INC | $13,953,000 | +12.9% | 3,802,000 | 0.0% | 0.18% | +26.2% | |
| BCR | BARD C R INC | $13,030,000 | +0.2% | 58,000 | 0.0% | 0.17% | +12.2% | |
| DERM | DERMIRA INC | $12,908,000 | -10.3% | 425,600 | 0.0% | 0.16% | 0.0% | |
| EXAS | Sell | EXACT SCIENCES CORP | $12,692,000 | -38.0% | 950,000 | -13.8% | 0.16% | -30.5% |
| FLDM | FLUIDIGM CORP DEL | $12,712,000 | -9.1% | 1,746,100 | 0.0% | 0.16% | +1.9% | |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $12,376,000 | +46.9% | 551,500 | +48.7% | 0.16% | +64.6% |
| IMGN | IMMUNOGEN INC | $12,435,000 | -23.9% | 6,095,647 | 0.0% | 0.16% | -15.1% | |
| ALXN | New | ALEXION PHARMACEUTICALS INCcall | $12,235,000 | – | 100,000 | +100.0% | 0.16% | – |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $12,144,000 | -3.3% | 345,700 | 0.0% | 0.16% | +8.4% | |
| FWP | FORWARD PHARMA A/Ssponsored adr | $11,970,000 | -28.5% | 798,000 | 0.0% | 0.15% | -19.9% | |
| VNDA | VANDA PHARMACEUTICALS INCcall | $11,963,000 | -4.1% | 750,000 | 0.0% | 0.15% | +7.0% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $11,903,000 | -0.9% | 169,300 | 0.0% | 0.15% | +10.9% | |
| ITEK | INOTEK PHARMACEUTICALS CORP | $11,281,000 | -35.7% | 1,849,300 | 0.0% | 0.14% | -28.0% | |
| PRQR | PROQR THRAPEUTICS N V | $11,297,000 | -26.5% | 2,305,446 | 0.0% | 0.14% | -17.7% | |
| LLY | Sell | LILLY ELI & COcall | $11,033,000 | -45.0% | 150,000 | -40.0% | 0.14% | -38.4% |
| SEM | New | SELECT MED HLDGS CORP | $11,023,000 | – | 831,900 | +100.0% | 0.14% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $10,201,000 | -23.1% | 7,259,620 | 0.0% | 0.13% | -13.9% | |
| NBRV | Buy | NABRIVA THERAPEUTICS AGsponsored adr | $10,001,000 | +7.9% | 1,677,940 | +27.6% | 0.13% | +19.8% |
| ABT | Sell | ABBOTT LABS | $9,426,000 | -49.4% | 245,400 | -44.3% | 0.12% | -43.4% |
| INCYTE CORPnote 1.250%11/1 | $8,670,000 | +4.9% | 4,250,000 | 0.0% | 0.11% | +17.0% | ||
| INCYTE CORPnote 0.375%11/1 | $8,496,000 | +5.0% | 4,250,000 | 0.0% | 0.11% | +17.4% | ||
| NUVA | NUVASIVE INC | $8,319,000 | +1.0% | 123,500 | 0.0% | 0.11% | +12.8% | |
| STDY | STEADYMED LTD | $7,988,000 | -27.6% | 3,072,196 | 0.0% | 0.10% | -19.0% | |
| XENE | XENON PHARMACEUTICALS INC | $7,700,000 | -4.9% | 1,000,000 | 0.0% | 0.10% | +6.5% | |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $7,541,000 | – | 372,191 | +100.0% | 0.10% | – |
| INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $7,354,000 | -23.0% | 7,000,000 | 0.0% | 0.09% | -13.8% | ||
| FLUIDIGM CORP DELnote 2.750% 2/0 | $7,013,000 | +12.9% | 10,000,000 | 0.0% | 0.09% | +25.4% | ||
| NERV | MINERVA NEUROSCIENCES INC | $6,535,000 | -16.8% | 556,200 | 0.0% | 0.08% | -6.7% | |
| SIEN | Sell | SIENTRA INC | $6,327,000 | -23.3% | 742,574 | -19.1% | 0.08% | -13.8% |
| TSRO | New | TESARO INC | $6,347,000 | – | 47,200 | +100.0% | 0.08% | – |
| AFMD | AFFIMED N V | $6,075,000 | -35.3% | 3,375,000 | 0.0% | 0.08% | -28.0% | |
| New | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $5,976,000 | – | 8,000,000 | +100.0% | 0.08% | – | |
| CLLS | CELLECTIS S Asponsored ads | $5,933,000 | -29.6% | 350,000 | 0.0% | 0.08% | -20.8% | |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $5,909,000 | -24.7% | 564,900 | 0.0% | 0.08% | -15.7% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $5,917,000 | -32.1% | 1,360,224 | 0.0% | 0.08% | -24.2% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $5,430,000 | -52.7% | 757,365 | 0.0% | 0.07% | -47.3% | |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $5,057,000 | -94.6% | 49,000 | -93.2% | 0.06% | -94.0% |
| INFI | INFINITY PHARMACEUTICALS INC | $4,388,000 | -13.5% | 3,250,300 | 0.0% | 0.06% | -3.4% | |
| ROKA | New | ROKA BIOSCIENCE INC | $3,788,000 | – | 893,470 | +100.0% | 0.05% | – |
| NVTA | INVITAE CORP | $3,626,000 | -9.4% | 456,666 | 0.0% | 0.05% | 0.0% | |
| AMED | AMEDISYS INC | $3,048,000 | -10.1% | 71,500 | 0.0% | 0.04% | 0.0% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,933,000 | -42.5% | 724,184 | 0.0% | 0.04% | -36.2% | |
| VRX | VALEANT PHARMACEUTICALS INTL | $2,830,000 | -40.9% | 194,900 | 0.0% | 0.04% | -33.3% | |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $2,682,000 | – | 300,000 | +100.0% | 0.03% | – |
| PTCT | New | PTC THERAPEUTICS INC | $2,230,000 | – | 204,400 | +100.0% | 0.03% | – |
| SGMO | Sell | SANGAMO BIOSCIENCES INC | $2,158,000 | -43.9% | 707,400 | -14.9% | 0.03% | -38.6% |
| OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $1,465,000 | +1.7% | 5,210,000 | 0.0% | 0.02% | +18.8% | ||
| AMRN | AMARIN CORP PLCspons adr new | $1,078,000 | -3.5% | 350,000 | 0.0% | 0.01% | +7.7% | |
| BLRX | BIOLINERX LTDsponsored adr | $956,000 | -19.9% | 1,038,600 | 0.0% | 0.01% | -14.3% | |
| NVLNF | New | NOVELION THERAPEUTICS INC | $842,000 | – | 100,000 | +100.0% | 0.01% | – |
| BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $589,000 | -5.6% | 500,000 | 0.0% | 0.01% | +14.3% | ||
| BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $562,000 | -6.3% | 500,000 | 0.0% | 0.01% | 0.0% | ||
| MRNS | MARINUS PHARMACEUTICALS INC | $573,000 | -44.5% | 567,600 | 0.0% | 0.01% | -41.7% | |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $301,000 | -8.8% | 68,143 | 0.0% | 0.00% | 0.0% | |
| MDGS | MEDIGUS LTDsponsored adr | $339,000 | -55.2% | 600,000 | 0.0% | 0.00% | -55.6% | |
| XTNT | XTANT MED HLDGS INC | $261,000 | -51.4% | 475,439 | 0.0% | 0.00% | -50.0% | |
| ALIM | ALIMERA SCIENCES INC | $270,000 | -27.6% | 250,000 | 0.0% | 0.00% | -25.0% | |
| NVLS | Exit | NIVALIS THERAPEUTICS INC | $0 | – | -59,000 | -100.0% | -0.01% | – |
| PTX | Exit | PERNIX THERAPEUTICS HLDGS IN | $0 | – | -1,073,000 | -100.0% | -0.01% | – |
| QLTI | Exit | QLT INC | $0 | – | -500,000 | -100.0% | -0.01% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INCcall | $0 | – | -90,000 | -100.0% | -0.02% | – |
| CGNT | Exit | COGENTIX MED INC | $0 | – | -878,145 | -100.0% | -0.02% | – |
| ROKA | Exit | ROKA BIOSCIENCE INC | $0 | – | -3,220,429 | -100.0% | -0.02% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -12,000,000 | -100.0% | -0.04% | – | |
| QURE | Exit | UNIQURE NV | $0 | – | -489,000 | -100.0% | -0.04% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -100,000 | -100.0% | -0.06% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -235,400 | -100.0% | -0.12% | – |
| AGN | Exit | ALLERGAN PLCcall | $0 | – | -50,000 | -100.0% | -0.13% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -2,159,973 | -100.0% | -0.18% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -261,800 | -100.0% | -0.18% | – |
| CYNA | Exit | CYNAPSUS THERAPEUTICS INC | $0 | – | -499,999 | -100.0% | -0.23% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -350,000 | -100.0% | -0.25% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -325,700 | -100.0% | -0.48% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -1,166,200 | -100.0% | -0.61% | – |
| AGNPRA | Exit | ALLERGAN PLCpfd conv ser a | $0 | – | -88,200 | -100.0% | -0.82% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -6,206,300 | -100.0% | -0.90% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -3,787,500 | -100.0% | -1.02% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -1,451,900 | -100.0% | -1.17% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -1,248,000 | -100.0% | -1.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.